Oncology companies

BARD1 Life Sciences is a company focused on developing and commercializing non-invasive diagnostic tests for early detection of cancer.

Neoleukin Therapeutics is a company developing medicines to treat immunological disorders, such as cancer and autoimmunity.

Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases.

Tempest Therapeutics is a developer of targeted and immune-mediated cancer therapies.

OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.

Nuvectis Pharma (formerly known as Centry Pharma) is a biopharmaceutical company focused on precision medicines for cancer treatment.

MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases.

MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

Elevation Oncology is a biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers.

Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.

Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides.